The Latest on the Government Shutdown

The Week in Review House Democrats forced Republicans to vote against some of their own drug pricing bills last week by packaging them with measures intended to shore up the Affordable Care Act (ACA). As part of the package, Democrats voted on three bills that would help remove barriers to generic drugs entering the market […]

It is going to be a busy week in the House of Representatives with two major financial services related bills coming to the floor. First is H.R. 1500, legislation offered by Chair Waters that will roll back many of the changes made to the CFPB by former Acting Director Mick Mulvaney. While the legislation had […]

Congressional lawmakers will convene for legislative business next week prior to leaving for a Memorial Day district work period. On the House floor, lawmakers will take up a comprehensive, bipartisan retirement savings package (H.R. 1994) that seeks to: (1) boost incentives for retirement savings; (2) allow small businesses to band together and start multi-employer 401(k)s; […]

House lawmakers will begin consideration of a package (rules committee print) of health care bills aimed at addressing prescription drug pricing and rolling back Trump-era ACA regulations. While a significant portion of the legislation pertaining to drug pricing enjoys bipartisan support — such as provisions that target “pay-for-delay” settlements (H.R. 1499) and generic “parking” (H.R. 938) — the […]

Senate GOP leadership expressed optimism about striking a deal to provide funding for states impacted by recent natural disasters, signaling a possible end to the monthslong impasse over the disaster relief funds. Senate Appropriations Chairman Richard Shelby (R-AL) noted yesterday that the prospects for a deal “have improved dramatically,” suggesting that the disagreements over aid […]

House lawmakers will begin their legislative work week later this afternoon, kicking off the week with a full slate of suspension bills. Among the 13 bills up for consideration, lawmakers will likely pass a Financial Services measure (H.R. 2578) that would extend the National Flood Insurance Program (NFIP) through Sept. 30. The short-term reauthorization for […]

If you were watching your stock portfolios this past week there was a lot of movement – most of it downward – due to concerns about the impact of a potential escalation in the ongoing trade war between the US and China. Given the eccentric management style of this President it is hard to predict […]

Key health care legislation will be on the House floor again this week as Democratic leadership has set up votes on a package (rules committee print) of bills aimed at addressing prescription drug pricing and rolling back Trump-era ACA regulations. While a significant portion of the legislation pertaining to drug pricing enjoys bipartisan support — such as […]

The Week in Review Health care legislation cleared the House floor last week as lawmakers passed a slew bills pertaining to drug pricing and the Affordable Care Act (ACA). The House passed a bill (H.R. 986) that would prohibit the Departments of Health and Human Services (HHS) and Treasury from taking any action to implement, […]

House lawmakers are set to vote on another disaster relief bill (text; summary) in hopes of breaking a months-long impasse over the emergency funds. The latest $17.2 billion offer from House Appropriations Chairwoman Nita Lowey (D-NY) includes additional funding for Army Corps of Engineers projects, Community Development Block Grant-Disaster Recovery (CDBG-DR) assistance, and the Department of […]

House Democrats are set to take another step toward reversing Trump-era regulations pertaining to the Affordable Care Act (ACA). Lawmakers will vote on a bill (H.R. 986) that would prohibit the Departments of Health and Human Services (HHS) and Treasury from taking any action to implement, enforce, or otherwise give effect to the Trump Administration’s […]

House Democrats are set to address their broad goal of addressing prescription drug prices with a vote on two incremental pieces of legislation. The drug pricing suspension bills (H.R. 1503 and H.R. 1520) up for consideration today would respectively update the FDA’s Orange Book and Purple Book to provide better information on brand drug and biologic patent […]